A new look at viruses in type 1 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 19, Issue 1, 2003, Pages 8-31

  Jun, Hee Sok ^a   Yoon, Ji Won ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Beta cell specific autoimmunity; Environmental factor; Type 1 diabetes; Virus; Virus mediated autoimmunity

Indexed keywords

VIRUS PROTEIN; VIRUS RECEPTOR;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CATTLE DISEASE; CELL DESTRUCTION; CELL SPECIFICITY; COXSACKIE VIRUS B; CYTOLYSIS; CYTOMEGALOVIRUS; ENCEPHALOMYOCARDITIS VIRUS; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; GENETIC PREDISPOSITION; HUMAN; INFECTION SENSITIVITY; INFLUENZA VIRUS; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MENGO VIRUS; MUMPS VIRUS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; REOVIRUS; RETROVIRUS; REVIEW; RISK FACTOR; RUBELLA VIRUS; TRANSGENIC ANIMAL;

ANIMALS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; HUMANS; ISLETS OF LANGERHANS; MICE; RATS; VIRUS DISEASES;

EID: 0037217057     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.337     Document Type: Review

References (230)

1. Yoon JW, Jun HS. Insulin-dependent diabetes mellitus. In Encyclopedia of Immunology (2nd edn), Roitt IM, Delves PJ (eds). Academic Press: London, 1998; 1390-1398.
2. Lernmark A, Falorni A. Immune phenomena, events in the islets in insulin-dependent diabetes mellitus. In Textbook of Diabetes (2nd edn), Pickup JC, Williams G (eds). Blackwell Science: Oxford, 1997; 15.1-15.23.
3. Rossini AA, Greiner DL, Friedman HP, Mordes JP. Immunopathogenesis of diabetes mellitus. Diabetes Rev 1993; 1: 43-75.
4. Atkinson MA, McLaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331: 1428-1436.
5. Bach JF. Insulin-dependent diabetes mellitus as a β cell targeted disease of immunoregulation. J Autoimmun 1995; 8: 439-463.
6. Verge CF, Eisenbarth GS. Prediction of type I diabetes: the natural history of the prediabetic period. In Type I Diabetes: Molecular, Cellular, Clinical Immunology, Eisenbarth GS, Lafferty KJ (eds). Oxford University Press: New York, 1996; 230-258.
7. Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996; 85: 291-297.
8. Pyke DA. The genetic perspective-putting research into practice. In Diabetes 1988, Larkins RG, Zimmet PZ, Chisholm DJ (eds). Exerpta Medica: Amsterdam, 1989; 1227-1230.
9. Horn G, Bugawan T, Long C, Erlich H. Allelic sequence of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proc Natl Acad Sci USA 1988; 85: 6012-6016.
10. Todd JA, Bain SC. A practical approach to identification of susceptibility genes for IDDM. Diabetes 1992; 41: 1029-1034.
11. Segall M. HLA and the genetics of IDDM: holism versus reductionism. Diabetes 1988; 37: 1005-1008.
12. Sheehy M, Scharf S, Rowe J, et al. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and DQ alleles. J Clin Invest 1989; 83: 830-835.
13. Barnett AH, Eff C, Leslie RDG, Pyke DA. Diabetes in identical twins. A study of 200 pairs. Diabetologia 1981; 20: 87-93.
14. Yoon JW. Pathogenesis of IDDM: environmental factors. In Textbook of Diabetes (2nd edn), Pickup JC, Williams G (eds). Blackwell Science: Oxford, 1997; 14.1-14.14.
15. Yoon JW, Jun HS. Role of viruses in the pathogenesis of type 1 diabetes mellitus. In Diabetes Mellitus: A Fundamental, Clinical Text, LeRoith D, Olefsky M (eds). Lippincott-Ravin: Philadelphia, 2000; 419-430.
16. Harris HF. A case of diabetes mellitus quickly following mumps on the pathological alterations of salivary glands, closely resembling those found in pancreas, in a case of diabetes mellitus. Boston Med Surg J 1898; CXL: 465.
17. Adams SF. The seasonal variation in the onset of acute diabetes. Arch Intern Med 1926; 37: 861,862.
18. Gamble DR, Taylor KW. Seasonal incidence of diabetes mellitus. Br Med 1969, 13: 631-633.
19. Szopa TM, Titchener PA, Portwood ND, Taylor KW. Diabetes mellitus due to viruses - some recent developments. Diabetologia 1993; 36: 687-695.
20. King ML, Shaikh A, Bidwell D, Voller A, Banatvala JE. Coxsackie B-virus specific IgM responses in children with insulin-dependent diabetes mellitus. Lancet 1983; 1: 1397-1399.
21. Banatvala JE, Bryant J, Schernthaner G, et al. Coxsackie B, mumps, rubella and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria and Australia. Lancet 1985; 1: 1409-1412.
22. Friman G, Fohlman J, Frisk G, et al. An incidence peak of juvenile diabetes. Relation to Coxsackie B virus immune response. Acta Pediatr Scand 1985; 320(Suppl.): 14-19.
23. Champsaur H, Bottazzo G, Bertrams J, Assan R, Bach C. Virologic, immunologic and genetic factors in insulin-dependent diabetes mellitus. J Pediatrics 1982; 100: 15-20.
24. Yoon JW, Austin M, Onodera T, Notkins AL. Virus-induced diabetes mellitus: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300: 1173-1179.
25. Yoon JW, Kominek HI. Role of Coxsackie B viruses in the pathogenesis of diabetes mellitus. In Microorganisms, Autoimmune Diseases, Rose NR, Friedman H (eds). Plenum Press: New York, 1996; 129-158.
26. Gladisch R, Hoffmann W, Waldherr R. Myocarditis and insulitis following Coxsackie virus infection. Z Kardiol 1976; 65: 837-849.
27. Jensen A, Rosenberg H, Notkins AL. Virus-induced diabetes mellitus XVII: pancreatic islet cell damage in children with fatal viral infections. Lancet 1980; 2: 354-358.
28. Ginsberg-Fellner F, Fedun B, Cooper LZ, et al. Interrelationships of congenital rubella, type 1 insulin-dependent diabetes mellitus. In The Immunology of Diabetes Mellitus, Jaworski MA, Molnar GD, Rajotte RV, Singh B (eds). Elsevier: Amsterdam, 1986; 279-286.
29. Ginsberg-Fellner F, Witt ME, Yagihaski S. Congenital rubella-syndrome as a model for type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. Diabetologia 1984; 27: 87-89.
30. Gamble DR. Relation of antecedent illness to development of diabetes in children. Br Med J 1980; 2: 99-101.
31. Helmke K, Otten A, Willems W. Islet cell antibodies in children with mumps infection. Lancet 1980; 2: 211-212.
32. Ward KP, Galloway WH, Auchterlonie IA. Congenital cytomegalovirus infection and diabetes. Lancet 1979; 1: 497.
33. Yasumoto N, Hara M, Kitamoto YU, Nakayama M, Sato T. Cytomegalovirus infection associated with acute pancreatitis, rhabdomyolysis and renal failure. Intern Med 1992; 31: 426-430.
34. Pak CY, Eun HM, McArthur RG, Yoon JW. Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 1988; 2: 1-4.
35. Chikazawa K, Okusa H, Minakami H, Kimura K, Araki S, Tamada T. Acute onset of insulin-dependent diabetes mellitus caused by Epstein-Barr virus infection. Acta Obstet Gynecol Jpn 1985; 37: 453-456.
36. Surcel HM, Ilonen J, Kaar ML, Hyöty H, Leinikki P. Infection by multiple viruses and lymphocyte abnormalities at the diagnosis of diabetes. Acta Paediatr Scand 1988; 77: 471-474.
37. Jali MV, Shankar PS. Transient diabetes following chicken pox. J Assoc Physicians India 1990; 38: 663-664.
38. Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997; 90: 303-313.
39. Stauffer Y, Marguerat S, Meylan F, et al. Interferon-alpha-induced endogenous superantigen: a model linking environment and autoimmunity. Immunity 2001; 15: 591-601.
40. Honeyman MC, Coulson BS, Stone NL, et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 2000; 49: 1319-1324.
41. Craighead JE, McLane MF. Diabetes mellitus: induction in mice by encephalomyocarditis virus. Science 1968; 162: 913-915.
42. Yoon JW, McClintock PR, Onodera T, Notkins AL. Virus induced diabetes mellitus XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus. J Exp Med 1980; 152: 878-892.
43. Yoon JW, Morishima T, McClintock PR, Austin M, Notkins AL. Virus-induced diabetes mellitus: mengovirus infects pancreatic beta cells in strains of mice resistant to encephalomyocarditis virus. J Virol 1984; 50: 684-690.
44. Onodera T, Jenson AB, Yoon JW, Notkins AL. Virus-induced diabetes mellitus: reovirus infection of pancreatic beta cells in mice. Science 1978; 301: 529-531.
45. Suenaga K, Yoon JW. Association of beta cell-specific expression of endogenous retrovirus with the development of insulitis and diabetes in NOD mice. Diabetes 1988; 37: 1722-1726.
46. Gaskins H, Prochazka M, Hamaguchi K, Serreze D, Leiter E. Beta cell expression of endogenous xenotropic retrovirus distinguishes diabetes-susceptible NOD/Lt from resistant NON/Lt mice. J Clin Invest 1992; 90: 2220-2227.
47. Nakagawa C, Hanafusa T, Miyagawa J, et al. Retrovirus gag protein p30 in the islets of nonobese diabetic mice: relevance for pathogenesis of diabetes mellitus. Diabetologia 1992; 35: 614-618.
48. Yoon JW, Onodera T, Notkins AL. Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with Coxsackie virus B4. J Exp Med 1978; 148: 1068-1080.
49. Hou J, Sheikh S, Martin DL, Chatterjee NK. Coxsackie virus B4 alters pancreatic glutamic decarboxylase expression in mice soon after infection. J Autoimmun 1993; 6: 529-542.
50. Yoon JW, London WT, Curfman BL, Brown RL, Notkins AL. Coxsackie virus B4 produces transient diabetes in nonhuman primates. Diabetes 1986; 35: 712-716.
51. Barboni E, Manocchio I, Asdrubali G. Observations on diabetes mellitus associated with experimental foot-and-mouth disease in cattle. Vet Ital 1966; 17: 362-368.
52. Menser MA, Forrest JM, Bransby RD. Rubella infection and diabetes mellitus. Lancet 1978; 1: 57-60.
53. Rayfield E, Kelly K, Yoon JW. Rubella virus-induced diabetes in hamsters. Diabetes 1986; 35: 1276-1281.
54. Tajima M, Yazawa T, Hagiwara K, Kurosawa T, Takahashi K. Diabetes mellitus in cattle infected with bovine viral diarrhea mucosal disease virus. J Vet Med A 1992; 39: 616-620.
55. Guberski DL, Thomas VA, Shek WR, et al. Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science 1991; 254: 1010-1013.
56. Oldstone MBA. Prevention of type 1 diabetes in nonobese diabetic mice by virus infection. Science 1988; 239: 500-502.
57. Dyrberg T, Schwimmbeck PL, Oldstone MBA. Inhibition of diabetes in BB rats by viral infection. J Clin Invest 1988; 81: 928-931.
58. Wilberz S, Partke HJ, Dagnaes-Hansen F, Herberg L. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia 1991; 34: 2-5.
59. Schattner A, Rager-Zisman B. Virus-induced autoimmunity. Rev Infect Dis 1990; 12: 204-222.
60. Talal N, Flescher E, Dang H. Are endogenous retroviruses involved in human autoimmune disease? J Autoimmun 1992; 5(Suppl. A): 61-66.
61. Pak CY, Jun HS, Lee M, Yoon JW. Beta cell-specific expression of retroviral mRNAs and group-specific antigen and the development of beta cell-specific autoimmunity in non-obese diabetic mice. Autoimmunity 1995; 20: 19-24.
62. Fukino-Kurihara H, Fujita H, Hakura A, Nonaka K, Tarui S. Morphological aspects on pancreatic islets of non-obese diabetic (NOD) mice. Virchows Arch 1985; 49: 107-120.
63. Lee KU, Amano K, Yoon JW. Evidence for initial involvement of macrophages in development of insulitis in NOD mice. Diabetes 1988; 37: 1989-1991.
64. Charlton B, Bacelj A, Mandel TE. Administration of silica particles or anti-Lyt2 antibody prevents β-cell destruction in NOD mice given cyclophosphamide. Diabetes 1988; 37: 930-935.
65. Jun HS, Yoon CS, Zbytnuik L, van Rooijen N, Yoon JW. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Exp Med 1999; 189: 347-358.
66. Hao W, Serreze DV, McCulloch DK, Neifing JL, Palmer JP. insulin (auto) antibodies from human IDDM cross-react with retroviral antigen p73. J Autoimmun 1993; 6: 787-798.
67. gag antigen. Cell 1987; 51: 211-220.
68. Nyman U, Lundberg I, Hedfors E, Pettersson I. Recombinant 70-kD protein used for determination of autoantigenic epitopes recognized by anti-RNP sera. Clin Exp Immunol 1990; 81: 52-58.
69. Brookes SM, Pandolfino YA, Mitchell TJ, et al. The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br J Rheumatol 1992; 31: 735-742.
70. Kim A, Jun HS, Wong L, et al. Human endogenous retrovirus with a high genomic sequence homology with IDDMK(1,2)22 is not specific for type I (insulin-dependent) diabetic patients but ubiquitous. Diabetologia 1999; 42: 413-418.
71. Lower R, Tonjes RR, Boller K, et al. Development of insulin-dependent diabetes mellitus does not depend on specific expression of the human endogenous retrovirus HERV-K. Cell 1998; 95: 11-14.
72. Onodera T, Toniolo A, Ray UR, Jenson AB, Knazek RA, Notkins AL. Virus-induced diabetes mellitus. J Exp Med 1981; 153: 1457-1465.
73. Onodera T, Ray UR, Melez KA, Suzuki H, Toniolo A, Notkins AL. Virus-induced diabetes mellitus: autoimmunity and polyendocrine disease prevented by immunosuppression. Nature 1982; 297: 66-69.
74. Hayashi T, Morimoto M, Iwata H, Onodera T. Possible involvement of IL-12 in reovirus type-2-induced diabetes in newborn DBA/1 mice. Scand J Immunol 2001; 53: 572-578.
75. Yoon JW, Selvaggio S, Onodera T, Wheeler J, Jenson AB. Infection of cultured human pancreatic β cell with reovirus type 3. Diabetologia 1981; 20: 462-467.
76. Brown DW, Welsh RM, Like AA. Infection of peripancreatic lymph nodes but not islets precedes Kilham's rat virus-induced diabetes in BB/Wor rats. J Virol 1993; 67: 5873-5878.
77. Marliss EB. The juvenile diabetes foundation workshop on spontaneously diabetic BB rat as potential for insight into human juvenile diabetes. Metab Clin Exp 1983; 32(Suppl. 1): 1-166.
78. Chung YH, Jun HS, Hirasawa K, Lee BR, van Rooijen N, Yoon JW. Role of macrophages and macrophage-derived cytokines in the pathogenesis of Kilham rat virus-induced autoimmune diabetes in diabetes-resistant BB rats. J Immunol 1997; 159: 466-471.
79. Doukas J, Mordes JP, Swymer C, et al. Thymic epithelial defects and predisposition to autoimmune disease in BB rats. Am J Pathol 1994; 145: 1517-1525.
80. + T lymphocytes induces diabetes in resistant BioBreeding/Worcester (BB/W) rats. J Exp Med 1987; 166: 461-475.
81. Ellerman KE, Richards CA, Guberski DL, Shek WR, Like AA. Kilham rat virus triggers T-cell-dependent autoimmune diabetes in multiple strains of rat. Diabetes 1996; 45: 557-562.
82. Chung YH, Jun HS, Son M, et al. Cellular and molecular mechanism for Kilham rat virus-induced autoimmune diabetes in DR-BB rats. J Immunol 2000; 165: 2866-2876.
83. Ellerman K, Wrobleski M, Rabinovitch A, Like A. Natural killer cell depletion and diabetes mellitus in the BB/Wor rat (revisited). Diabetologia 1993; 36: 596-601.
84. Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation? Diabetes 1994; 43: 613-621.
85. + T cells in the pathogenesis of organ-specific autoimmune disease. Immunol Today 1995; 16: 34-38.
86. Delovitch T, Singh B. The nonobese diabetic mouse as a model of autoinumme disease: immune dysregulation gets the NOD. Immunity 1997; 7: 727-738.
87. Tajima M, Yuasa M, Kawanabe M, Taniyama H, Yamato O, Maede Y. Possible causes of diabetes mellitus in cattle infected with bovine diarrhoea virus. Zentralbl Veterinarmed B 1999; 46: 207-215.
88. Prince G, Jenson AB, Billups L, Notkins AL. Infection of human pancreatic beta cell cultures with mumps virus. Nature 1978; 27: 158-161.
89. Cavallo MG, Baroni MG, Toto A, et al. Viral infection induces cytokine release by beta islet cells. Immunology 1992; 75: 664-668.
90. Parkkonen P, Hyöty H, Koskinen L, Leinikki P. Mumps virus infects beta cells in human fetal islet cell cultures upregulating the expression of HLA class I molecules. Diabetologia 1992; 35: 63-69.
91. Vuorinen T, Nikolakaros G, Simell O, Hyypia T, Vainionpaa R. Mumps and Coxsackie B3 virus infection of human fetal pancreatic islet-like cell clusters. Pancreas 1992; 7: 460-464.
92. Hyöty H, Hiltunen M, Reunanen A, et al., Childhood Diabetes in Finland Study Group. Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Diabetologia 1993; 36: 1303-1308.
93. Hummel M, Fuchtenbusch M, Schenker M, Ziegler AG. No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB study. Diabetes Care 2000; 24: 969-974.
94. DeStafano F, Mullooly JP, Okoro CA, et al., Vaccine Safety Datalink Team. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics 2001; 108: E112.
95. Patterson K, Chandra R, Jenson A. Congenital rubella, insulitis and diabetes mellitus in an infant. Lancet 1981; 1: 1048-1049.
96. Schopfer K, Matter L, Flueler U, Werder E. Diabetes mellitus, endocrine autoantibodies and prenatal rubella infection. Lancet 1982; 2: 159.
97. Menser MA, Forrest J, Bransby R. Rubella infection and diabetes mellitus. Lancet 1978; 1: 57-60.
98. Forrest J, Menser MA, Burgess J. High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 1971; 1: 332-334.
99. McEvoy R, Cooper L, Rubinstein P, Fedun B, Ginsberg-Feliner F. Type I diabetes mellitus (IDDM) and autoimmunity in patients with congenital rubella syndrome (CRS): increased incidence of insulin autoantibodies. Diabetes 1986; 35: 187A.
100. Rabinowe S, George K, Loughlin R, Soeldner J. Predisposition to type I diabetes and organ-specific autoimmunity in congenital rubella: T cell abnormalities in young adults. Diabetes 1986. 35: 187A.
101. Ginsberg-Feliner F, Witt ME, Fedun B. Diabetes mellitus and autoimmunity in patients with congenital rubella syndrome. Rev Infect Dis 1985; 7(Suppl. 1): S170-S175.
102. McIntosh EDG, Menser MA. A fifty-year follow-up of congenital rubella. Lancet 1992; 340: 414-415.
103. Numazaki K, Goldman H, Wong I, Wainberg MA. Infection of cultured human fetal pancreatic islet cells by rubella virus. Am J Clin Pathol 1989; 91: 446-451.
104. Numazaki K, Goldman H, Seemayer TA, Wong I, Wainberg MA. Infection by human cytomegalovirus and rubella virus of cultured human fetal islets of Langerhans. In Vivo 1990; 4: 49-54.
105. Karounos DG, Wolinsky JS, Thomas JW. Monoclonal antibody to rubella virus capsid protein recognizes a beta-cell antigen. J Immunol 1993; 150: 3080-3085.
106. Ou D, Mitchell LA, Metzger DL, Gillam S, Tingle AJ. Cross-reactive rubella virus and glutamic acid decarboxylase (65 and 67) protein determinants recognized by T cells of patients with type 1 diabetes mellitus. Diabetologia 2000; 43: 750-762.
107. Jun HS, Khil LY, Yoon JW. Role of glutamic acid decarboxylase in the pathogenesis of type 1 diabetes. Cell Mol Life Sci 2002; in press.
108. Ivarsson SA, Lindberg B, Nilsson KO, Ahlfors K, Svanberg L. The prevalence of type 1 diabetes mellitus at follow-up of Swedish infants congenitally infected with cytomegalovirus. Diabetic Med 1993; 10: 521-523.
109. Nicoletti F, Scalia G, Lunetta M, et al. Correlation between islet cell antibodies and anti-cytomegalovirus IgM and IgG antibodies in healthy first-degree relatives of type 1 (insulin-dependent) diabetic patient. Clin Immunol Immunopathol 1990; 55: 139-147.
110. Pak CY, Cha CY, Rajotte RV, McArthur RG, Yoon JW. Human pancreatic islet cell-specific 38 kDa autoantigen identified by cytomegalovirus-induced monoclonal islet cell autoantibody. Diabetologia 1990; 33: 569-572.
111. Hiemstra HS, Schloot NC, van Veelen PA, et al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci USA 2001; 98: 3988-3991.
112. Hyöty H, Rasanen L, Hiltunen M, Lehtinen M, Huupponen T, Leinikki P. Decreased antibody reactivity to Epstein-Barr virus capsid antigen in type 1 (insulin-dependent) diabetes mellitus. APMIS 1991; 99: 359-363.
113. Parkkonen F, Hyöty H, Ilonen J, Reijonen H, Yla-Herttuala S, Leinikki P. Antibody reactivity to an Epstein-Barr virus BERF4-encoded epitope occurring also in Asp-57 region of HLA-DQ8 β chain. Clin Exp Immunol 1994; 95: 287-293.
114. Surcel HM, Ilonen J, Kaar ML, Hyöty H, Leinikki P. Infection by multiple viruses and lymphocyte abnormalities at the diagnosis of diabetes. Acta Paediatr Scand 1988; 77: 471-474.
115. Sairenji T, Daibata M, Sorli CH, et al. Relating homology between the Epstein-Barr virus BOLF1 molecule and HLADQw8 beta chain to recent onset type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1991; 34: 33-39.
116. Ohashi P, Oehen S, Buerki K, et al. Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991; 65: 305-317.
117. Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991; 65: 319-331.
118. von Herrath MG, Holz A, Homann D, Oldstone MB. Role of viruses in type I diabetes. Semin Immunol 1998; 10: 87-100.
119. von Herrath MG, Oldstone MB. Virus-induced autoimmune disease. Curr Opin Immunol 1996; 8: 878-885.
120. Roman L, Simons L, Hammer R, Sambrook J, Gething M. The expression of influenza virus hemagglutinin in the pancreatic beta cells of transgenic mice results in autoimmune diabetes. Cell 1990; 61: 383-396.
121. Holers VM, Hollis GF, Schwartz BD, et al. Induction of peri-insulitis but not diabetes in islet transplants expressing a single foreign antigen. A multi-stage model of disease. J Immunol 1993; 151: 5041-5052.
122. Ohashi PS, Oehen S, Aichele P, et al. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-α. J Immunol 1993; 150: 5185-5194.
123. Harlan DM, Hengartner H, Huang ML, et al. Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc Natl Acad Sci USA 1994; 91: 3137-3141.
124. Holz A, Brett K, Oldstone MB. Constitutive beta cell expression of IL-12 does not perturb self-tolerance but established autoimmune diabetes. J Clin Invest 2001; 108: 1749-1758.
125. Christen U, Wolfe T, Mohrle U, et al. A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J Immunol 2001; 166: 7023-7032.
126. Holz A, Bot A, Coon B, Wolfe T, Grusby MJ, von Herrath MG. Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence. J Immunol 1999; 163: 5374-5382.
127. Ludewig B, Zinkernagel RM, Hengartner H. Transgenic animal models for virus-induced autoimmune diseases. Exp Physiol 2000; 85: 653-659.
128. Coon B, An LL, Whitton JL, von Herrath MG. DNA immunization to prevent autoimmune diabetes. J Clin Invest 1999; 104: 189-194.
129. Scott B, Liblau R, Degermann S, et al. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1994; 1: 73-83.
130. + T cell-mediated spontaneous diabetes in neonatal mice. J Immunol 1996; 157: 978-983.
131. + T cell-mediated insulin-dependent diabetes mellitus. J Immunol 1999; 163: 4335-4341.
132. Stefan Y, Malaisse-Lagae F, Yoon JW, Notkins AL, Orci L. Virus-induced diabetes in mice: a quantitative evaluation of islet cell population by immunofluorescence technique. Diabetologia 1978; 15: 395-401.
133. Ross ME, Onodera T, Brown KS, Notkins AL. Virus-induced diabetes mellitus IV. Genetic and environmental factors influencing the development of diabetes after infection with the M variant of encephalomyocarditis virus. Diabetes 1976; 25: 190-197.
134. Yoon JW, Onodera T, Notkins AL. Virus-induced diabetes mellitus IX. Studies on virus passage and dose in susceptible and resistant strains of mice. J Gen Virol 1977; 27: 225-232.
135. Kang Y, Yoon JW. A genetically determined host factor controlling susceptibility to encephalomyocarditis virus-induced diabetes in mice. J Gen Virol 1993; 74: 1203-1213.
136. Bae YS, Eun HM, Yoon JW. Molecular identification of viral gene. Diabetes 1989; 38: 316-320.
137. Bae YS, Eun HM, Yoon JW. Genomic differences between the diabetogenic and non-diabetogenic variants of encephalomyocarditis virus. Virology 1989; 170: 282-287.
138. Bae YS, Yoon JW. Determination of diabetogenicity attributable to a single amino acid, Ala-776, on the polyprotein of encephalomyocarditis virus. Diabetes 1993; 42: 435-443.
139. Jun HS, Kang Y, Notkins AL, Yoon JW. Gain or loss of diabetogenicity resulting from a single point mutation in recombinant encephalomyocarditis virus. J Virol 1997; 71: 9782-9785.
140. Jun HS, Yoon JW. The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals. Diabetologia 2001; 44: 271-285.
141. Eun HM, Bae YS, Yoon JW. Amino acid differences in capsid protein, VP1, between diabetogenic and nondiabetogenic variants of encephalomyocarditis virus. Virology 1988; 163: 369-373.
142. Kaptur PE, Thomas DC, Giron DJ. Differing attachment of diabetogenic and nondiabetogenic variants of encephalomyocarditis virus to beta-cells. Diabetes 1989; 38: 1103-1108.
143. Jun HS, Kang Y, Yoon HS, Kim KH, Notkins AL, Yoon JW. Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein. Diabetes 1998; 47: 576-582.
144. Onodera T, Yoon JW, Brown K, Notkins AL. Virus-induced diabetes mellitus: evidence for control by a single locus. Nature 1978; 274: 693-696.
145. Yoon JW, Lesniak MA, Fussganger R, Notkins AL. Genetic differences in susceptibility of pancreatic β cells to virus-induced diabetes mellitus. Nature 1976; 264: 178-180.
146. Chairez R, Yoon JW, Notkins AL. Virus-induced diabetes mellitus X. Attachment of encephalomyocarditis virus and permissiveness of cultured β cells to infection. Virology 1978; 85: 606-611.
147. Yoon JW, Notkins AL. Virus-induced diabetes mellitus VI. Genetically determined host differences in the replication of encephalomyocarditis virus in pancreatic B-cells. J Exp Med 1976; 143: 1170-1185.
148. Buschard K, Hastrup N, Rygaard J. Virus-induced diabetes mellitus in mice and the thymus-dependent immune system. Diabetologia 1983; 24: 42-46.
149. Yoon JW, McClintock PR, Bachurski CJ, Longstreth JD, Notkins AL. Virus-induced diabetes mellitus. No evidence for immune mechanisms in the destruction of beta cells by encephalomyocarditis virus. Diabetes 1985; 34: 922-925.
150. Vialettes B, Baume D, Charpin C, DeMaeyer-Guignard J, Vague P. Assessment of viral and immune factors in EMC virus-induced diabetes: effects of cyclosporin A and interferon. J Clin Lab Immunol 1983; 10: 35-40.
151. Baek HS, Yoon JW. Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J Virol 1990; 64: 5708-5715.
152. Baek HS, Yoon JW. Direct involvement of macrophages in destruction of β cells leading to the development of diabetes in virus-infected mice. Diabetes 1991; 40: 269-274.
153. Hirasawa K, Jun HS, Han HS, Zhang M-L, Hollenberg M, Yoon JW. Prevention of encephalomyocarditis virus-induced diabetes in mice by inhibition of the tyrosine signalling pathway and suppression of nitric oxide production in macrophages. J Virol 1999; 73: 8541-8548.
154. Hirasawa K, Jun HS, Maeda K, et al. Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J Virol 1997; 71: 4024-4031.
155. Choi KS, Jun HS, Kim HN, et al. Role of Hck in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J Virol 2001;75:1949-1957.
156. Yoon JW, Rodrigues MM, Currier C, Notkins AL. Long term complications of virus-induced diabetes in mice. Nature 1982; 296: 567-569.
157. Yoon JW, Reddi AH. Decreased bone formation and mineralization in virus induced diabetes mellitus. Am J Physiol 1984; 246: C177-C179.
158. Shichinohe K, Shimizu M, Ishizaki M, Asakawa M. Kidney complications in EMC virus-induced diabetes in conventional DBA/2 male mice. Exp Anim 1990; 39: 113-116.
159. Morishima T, McClintock PR, Auklakh GS, Billups LC, Notkins AL. Genomic and receptor attachment difference between mengovirus and encephalomyocarditis virus. Virology 1982; 122: 461-465.
160. Gamble DR, Kinsley ML, Fitzgerald MG, Bolton R, Taylor KW. Viral antibodies in diabetes mellitus. Br Med J 1969; 3: 627-630.
161. Hiltunen M, Hyoty H, Knip M, et al., Childhood Diabetes in Finland (DiMe) Study Group. Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. J Infect Dis 1997; 175: 554-560.
162. Lonnrot M, Korpela K, Knip M, et al. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish diabetes prediction and prevention study. Diabetes 2000; 49: 1314-1318.
163. Mertens T, Gruneklee D, Eggers HJ. Neutralizing antibodies against Coxsackie B viruses in patients with recent onset of type 1 diabetes. Eur J Pediatr 1983; 140: 293,294.
164. Frisk G, Fohlman J, Kobbah M, et al. High frequency of Coxsackie-B-virus-specific IgM in children developing during a period of high diabetes morbidity. J Med Virol 1985; 17: 219-227.
165. Fohlman J, Bohme J, Rask L, et al. Matching of host genotype, serotypes of Coxsackie B virus in the development of juvenile diabetes. Scand J Immunol 1987; 26: 105-110.
166. Frisk G, Friman G, Tuvemo T, Fohlman J, Diderholm H. Coxsackie B virus IgM in children at onset of type 1 (insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection. Diabetologia 1992; 35: 249-253.
167. Gamble DR, Taylor KW, Cumming H. Coxsackie viruses and diabetes mellitus. Br Med J 1973; 4: 260-262.
168. Wagenknecht L, Roseman J, Herman W. Increased incidence of insulin-dependent diabetes mellitus following an epidemic of Coxsackie virus B5. Am J Epidemiol 1991; 133: 1024-1031.
169. Helfand RF, Gary Jr HE, Freeman CY, Anderson LJ, Pallansch MA. Pittsburgh Diabetes Research Group. Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. J Infect Dis 1995; 172: 1206-1211.
170. Varela-Calvino R, Sgarbi G, Wedderburn LR, Dayan CM, Tremble J, Peakman M. T cell activation by coxsackievirus B4 antigens in type 1 diabetes mellitus: evidence for selective TCR Vbeta usage without superantigenic activity. J Immunol 2001; 167: 3513-3520.
171. Varela-Calvino R, Sgarbi G, Arif S, Peakman M. T-cell reactivity to the P2C nonstructural protein of a diabetogenic strain of coxsackievirus B4. Virology 2000; 274: 56-64.
172. Varela-Calvino R, Ellis R, Sgarbi G, Dayan CM, Peakman M. Characterization of the T-cell response to coxsackievirus B4: evidence that effector memory cells predominate in patients with type 1 diabetes. Diabetes 2002; 51: 1745-1753.
173. Juhela S, Hyöty H, Roivainen M, et al. T-cell responses to enterovirus antigens in children with type 1 diabetes. Diabetes 2000; 49: 1308-1313.
174. Lonnrot M, Salminen K, Knip M, et al., Childhood Diabetes in Finland (DiMe) Study Group. Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. J Med Virol 2000; 61: 214-220.
175. Nairn C, Galbraith DN, Taylor KW, Clements GB. Enterovirus variants in the serum of children at the onset of type 1 diabetes mellitus. Diabetes Med 1999; 16: 509-513.
176. Clements GB, Galbraith DN, Taylor KW. Coxsackie B virus infection and onset of childhood diabetes. Lancet 1995; 346: 221-223.
177. Andreoletti L, Hober D, Hober-Vandenberghe C, et al. Detection of Coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type 1 diabetes mellitus. J Med Virol 1997; 52: 121-127.
178. Yin H, Berg AK, Tuvemo T, Frisk G. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes 2002; 51: 1964-1971.
179. Otonkoski T, Roivainen M, Vaarala O, et al. Neonatal type I diabetes associated with maternal echovirus 6 infection: a case report. Diabetologia 2000; 43: 1235-1238.
180. Vreugdenhil GR, Schloot NC, Hoorens A, et al. Acute onset of type I diabetes mellitus after severe echovirus9 infection: putative pathogenic pathways. Clin Infect Dis 2000; 31: 1025-1031.
181. Lonnrot M, Knip M, Roivainen M, Koskela P, Akerblom HK, Hyoty H. Onset of type 1 diabetes mellitus in infancy after enterovirus infections. Diabetes Med 1998; 15: 431-444.
182. Graves PM, Norris JM, Pallansch MA, Gerling IC, Rewers M. The role of enteroviral infections in the development of IDDM: limitations of current approaches. Diabetes 1997; 46: 161-168.
183. Palmer JP, Cooney MK, Crossley JR, Hollander PH, Asplin CM. Antibodies to viruses and to pancreatic islets in nondiabetic and insulin-dependent diabetic patients. Diabetes Care 1981; 4: 525-528.
184. Pagano G, Cavallo-Perin P, Cavallo TF, et al. Genetic, immunologic, and environmental heterogeneity of IDDM. Incidence and 12 month follow-up of an Italian population. Diabetes 1987; 36: 859-863.
185. Marttila J, Juhela S, Vaarala O, et al. Responses of coxsackievirus B4-specific T-cell lines to 2C protein-characterization of epitopes with special reference to the GAD65 homology region. Virology 2001; 284: 131-141.
186. Pato E, Cour MI, Gonzalez-Cuadrado S, Gonzalez-Gomez C, Munoz JJ, Figueredo A. Coxsackie B4 and cytomegalovirus in patients with insulin-dependent diabetes. Ann Med Int 1992; 9: 30-32.
187. Palmer JP, Cooney MK, Ward RH, et al. Reduced Coxsackie antibody titres in type 1 (insulin-dependent) diabetic patients presenting during an outbreak of Coxsackie B3 and B4 infection. Diabetologia 1982; 22: 426-429.
188. Tuvemo T, Dahlquist G, Frisk G, et al. The Swedish childhood diabetes study III: IgM against Coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children - no evidence of increased antibody frequency. Diabetologia 1989; 32: 745-747.
189. Prabhakar BS, Haspel MV, McClintock PR, Notkins AL. High frequency of antigenic variants among naturally occurring human Coxsackie B4 virus isolates identified by monoclonal antibodies. Nature 1982; 300: 374-376.
190. Yoon JW, Bachurski CJ, McArthur RG. Concept of virus as an etiological agent in the development of IDDM. Diabetes Res Clin Pract 1986; 2: 365-366.
191. Notkins AL, Yoon JW. Virus-induced diabetes in mice prevented by a live attenuated vaccine. N Engl J Med 1982; 306: 486.
192. Wilson C, Connolly JM, Thomson D. Coxsackie B2 virus infection and acute onset diabetes in a child. Br Med J 1977; 1: 1008.
193. Ahmad N, Abraham AA. Pancreatic isletitis with Coxsackie virus B5 infection. Hum Pathol 1982; 13: 661-662.
194. Asplin CM, Cooney MK, Crossley JR, Dornan TL, Raghu P, Palmer JP. Coxsackie B4 infection and islet cell antibodies three years before overt diabetes. J Pediatr 1982; 101: 398-400.
195. Orchard TJ, Becker AJ, Atchison RW, et al. The development of type 1 (insulin-dependent) diabetes mellitus: two contrasting presentations. Diabetologia 1982; 25: 89-92.
196. Niklasson BS, Dobersen MJ, Peters CJ, Ennis WH, Moller E. An outbreak of Coxsackie-virus B infection followed by one case of diabetes mellitus. Scand J Infect Dis 1985; 17: 15-18.
197. Nigro G, Pacella ME, Patane E, Midulla M. Multi-system Coxsackievirus B-6 infection with findings suggestive of diabetes mellitus. Eur J Paediatr 1986; 145: 557-559.
198. Phillips WR, Pauli R. Simultaneous onset of insulin dependent diabetes mellitus in siblings. Lancet 1981; 2: 807.
199. Hyöty H, Hiltunen M, Knip M, et al., Childhood Diabetes in Finland (DiMe) Study Group. A prospective study of the role of Coxsackie B and other enterovirus infection in the pathogenesis of IDDM. Diabetes 1995; 44: 652-657.
200. Yoon JW, Onodera T, Notkins AL. Virus-induced diabetes mellitus XI. Replication of Coxsackie virus B3 in human pancreatic beta cell cultures. Diabetes 1978; 27: 778-782.
201. Szopa TM, Ward T, Taylor KW. Impaired metabolic functions in human pancreatic islets following infection with Coxsackie B4 virus in vitro. Diabetologia 1986; 30: 587A.
202. Ross ME, Hayashi K, Notkins AL. Virus-induced pancreatic disease: alterations in concentration of glucose and amylase in blood. Infect Dis 1974; 129: 669-676.
203. Toniolo A, Onodera T, Jordan G, Yoon JW, Notkins AL. Virus induced diabetes mellitus: glucose abnormalities produced in mice by all six members of the Coxsackie B virus group. Diabetes 1982; 31: 496-499.
204. Webb SR, Loria RM, Madge GF, Kibrick S. Susceptibility of mice to group B Coxsackie-virus is influenced by the diabetic gene. J Exp Med 1976; 143: 1239-1248.
205. Loria RM, Montgomery LB, Corey LA, Chinchilli VM. Influence of diabetes mellitus heredity on susceptibility to Coxsackievirus B4. Arch Virol 1984; 81: 251-262.
206. Loria RM, Montgomery LB, Tuttle-Fuller N, Gregg HM. Genetic predisposition to diabetes mellitus is associated with impaired humoral immunity to Coxsackievirus B4. Diabetes Res Clin Pract 1986; 2: 91-96.
207. Montgomery LB, Loria RM. Humoral immune response in hereditary and overt diabetes mellitus. J Med Virol 1986; 19: 255-268.
208. Montgomery LB, Loria RM, Chinchilli VM. Immunodeficiency as primary phenotype of diabetes mutation db. Studies with Coxsackie-virus B4. Diabetes 1990; 39: 675-682.
209. Chatterjee NK, Hou J, Dockstader P, Charbonnau T. Coxsackievirus B4 infection alters thymic, splenic and peripheral repertoire preceding onset of hyperglycemia in mice. Med Virol 1992; 38: 124-131.
210. Kang Y, Chatterjee NK, Nodwell MJ, Yoon JW. Complete nucleotide sequence of a strain of Coxsackie B4 virus of human origin that induces diabetes in mice and its comparison with non-diabetogenic Coxsackie B4 JBV strain. J Med Virol 1994; 44: 353-361.
211. Jenkins O, Booth JD, Minor PD, Almond JW. The complete nucleotide sequence of Coxsackievirus B4 and its comparison to other members of picornaviridae. J Gen Virol 1987; 68: 1835-1848.
212. Titchener PA, Jenkins O, Szopa TM, Taylor KW, Almond JW. Complete nucleotide sequence of a beta-cell tropic variant of Coxsackievirus B4. J Med Virol 1994; 42: 369-373.
213. Yoon JW, London W, Curfinan B, Brown R, Notkins AL. Coxsackie virus B4 produces transient diabetes in nonhuman primates. Diabetes 1986; 53: 712-716.
214. Prabhakar BS, Menegus MA, Notkins AL. Detection of conserved and nonconserved epitopes on Coxsackie virus B4: frequency of antigenic change. Virology 1985; 146: 302-306.
215. Fohlman J, Friman G. Is juvenile diabetes a viral disease? Ann Med 1993, 25: 569-574.
216. Frisk G, Nilsson E, Tuvemo T, Friman G, Diderholm H. The possible role of Coxsackie A and echo viruses in the pathogenesis of type 1 diabetes mellitus studied by IgM analysis. J Infect 1992; 24: 13-22.
217. Kaufman DL, Erlander MG, Clare-Salzler MJ, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992; 89: 283-292.
218. Hou J, Sheikh S, Martin DL, Chatterjee NK. Coxsackievirus B4 alters pancreatic glutamate decarboxylase expression in mice soon after infection. J Autoimmun 1993; 6: 529-542.
219. Hou J, Said C, Franchi D, Dockstader P, Chatterjee NK. Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from Coxsackie virus B4-infected mice and IDDM patients. Diabetes 1994; 43: 1260-1266.
220. Richter W, Mertens T, Schoel B, et al. Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with Coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies. J Exp Med 1994; 180: 721-726.
221. Tian J, Lehmann PV, Kaufman DL. T cell cross-reactivity between Coxsackie virus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp Med 1994; 180: 1979-1984.
222. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 1998; 4: 781-785.
223. Foulis AK, Farquharson MA, Cameron SO, McGill M, Schonke H, Kandolf R. A search for the presence of the enteroviral capsid protein VP1 in pancreata of patients with type 1 (insulin-dependent) diabetes and pancreata and hearts of infants who died of coxsackieviral myocarditis. Diabetologia 1990; 33: 290-298.
224. Foulis AK, Farquharson MA, Meager A. Immunoreactive α-interferon in insulin-producing β cells in type I diabetes mellitus. Lancet 1987; 2: 1423-1427.
225. Chehadeh W, Weill J, Vantyghem MC, et al. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackie B infection. J Infect Dis 2000; 181: 1929-1939.
226. Hermitte L, Vialettes B, Naquet P, Atlan C, Payan MJ, Vague P. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus. Eur J Immunol 1990; 20: 1297-1303.
227. Pak CY, Lee M, Yoon JW. Possible prevention of IDDM by vaccination with viral specific proteins. Pediatr Adol Endocrinol 1993; 22: 105-112.
228. Oldstone MBA. Viruses as therapeutic agents: I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence. J Exp Med 1990; 101: 2077-2089.
229. Oldstone MB, Ahmed R, Salvato M. Viruses as therapeutic agents: II. Viral reassortments map prevention of insulin-dependent diabetes mellitus to the small RNA of lymphocytic choriomeningitis virus. J Exp Med 1990; 171: 2091-2100.
230. Guberski DL, Butler L, Like AA. Environmental agents influence spontaneous and RT6 depletion induced diabetes (DB) in the BB/Wor rat. Diabetes 1990; 39: 97A.